The Siteman Approach
Our multidisciplinary team of Washington University Physicians, along with our nurses and other caregivers, have the specialization and experience you’ll need during every phase of your cancer journey.
Medical Therapy
Our specialized Washington University medical oncologists are national leaders in pioneering immunotherapies, targeted treatments, clinical trials, and other innovative medical therapies, which offer our patients the most advanced personalized treatment options available in the country.
Radiation
Our Washington University radiation oncologists have access to the most comprehensive radiation technology available. These nationally recognized physicians are specialized in their field and offer our patients the most advanced and innovative treatment options available in the country.
Surgery
Our nationally recognized Washington University surgeons lead some of the largest programs in the country, utilize the latest minimally invasive techniques, including robot-assisted technology, along with their wealth of experience and expertise, to provide outcomes that are among the very best in the country.
How We Personalize Your Cancer Care
Clinical Trials
Genetics
Imaging
Immunology
Pathology
Prevention
Our Locations
Latest News
Siteman Cancer Center expands to Illinois
Siteman Cancer Center opened its first treatment facility in Illinois on Aug. 1. The Swansea, Ill., facility marks Siteman’s sixth location overall. The treatment center offers convenient access to nationally recognized cancer care, including clinical…
Focused delivery for brain cancers
A person’s brainstem controls some of the body’s most important functions, including heart beat, respiration, blood pressure and swallowing. Tumor growth in this part of the brain is therefore twice as devastating. Not only can…
Scientists identify weak point in deadly eye melanoma
A natural plant compound exploits a newly identified Achilles’ heel in a cancer of the eye, uveal melanoma. In human cancer cells growing in the lab, the compound shuts down the overactive signaling that drives…